Tau protein in cerebrospinal fluid (CSF): a blood–CSF barrier related evaluation in patients with various neurological diseases
Authors:
- Hansotto ReiberHRHansotto Reiber
- Hayrettin TumaniHTHayrettin Tumani
- 1 March 2001
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 300 (2) , 95-98
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Increased Cerebrospinal Fluid Tau Protein in Multiple SclerosisEuropean Neurology, 2000
- The oligodendroglia cytoskeleton in health and diseaseJournal of Neuroscience Research, 2000
- Tau Protein in Cerebrospinal FluidAlzheimer Disease & Associated Disorders, 1998
- Intercellular adhesion molecule-1 in cerebrospinal fluid—the evaluation of blood-derived and brain-derived fractions in neurological diseasesJournal of Neuroimmunology, 1998
- Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt–Jakob diseaseNeuroscience Letters, 1997
- Soluble adhesion molecules (sVCAM‐1 and sICAM‐1) in cerebrospinal fluid and serum correlate with MRI activity in multiple sclerosisAnnals of Neurology, 1997
- Increased cerebrospinal fluid tau in patients with Alzheimer's diseaseNeuroscience Letters, 1995
- Pathological Tau proteins of Alzheimer's disease as a biochemical marker of neurofibrillary degenerationBiomedicine & Pharmacotherapy, 1994
- MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neurites: an immunocytochemical study of cultured rat cerebrumJournal of Neuroscience, 1987
- The distribution of tau in the mammalian central nervous system.Journal of Cell Biology, 1985